Infographic | February 26, 2022

Improving Efficiency In Cell Line Development

Source: Sartorius

The global market for biological products is growing, however the cost of developing a biologic drug remains high due to complex process development and manufacturing requirements. The success of a program hinges on the production of dedicated cell lines and early identification of top performers, as high yield products with optimal critical quality attributes significantly reduce production costs. Media and culture conditions are optimized to achieve higher cell growth and molecule yield.

Improve our cell line development (CLD) process by eliminating bottlenecks in clone selection, fast-tracking development timelines, and reducing the cost per experiment with these solutions.

access the Infographic!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Discovery Online